Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
American Journal of Obstetrics and Gynecology|October 1, 1992
Nifedipine treatment in preeclampsia reverts the increased erythrocyte aggregation to normalA L Tranquilli, G G Garzetti, G De Tommaso, et al.
Fetal Therapy|January 1, 1989
Umbilical cord blood rheology in relation to maternal disease and fetal hypoxiaC Romanini, A L Tranquilli, G G Garzetti, et al.
La Clinica Terapeutica|December 8, 2007
[Hepatic iron, iron depletion and response to therapy with peg-Interferon and Ribavirin in chronic hepatitis C. Pilot study]G Bertino, A M Ardiri, P M Boemi, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 1, 1992
[Hemo-rheologic changes following treatment with human recombinant erythropoietin in chronic hemodialysis patients]M Melappioni, R Giansanti, M Boemi, et al.
Diabetes, Nutrition & Metabolism|May 13, 2005
Microalbuminuria, brain vasomotor reactivity, carotid and kidney arterial flow in Type 2 diabetes mellitusF Gregorio, F Ambrosi, F Carle, et al.
Diabetes, Nutrition & Metabolism|December 4, 2004
Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patientsR Testa, A R Bonfigli, C Sirolla, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 3, 2016
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patientsA R Bonfigli, M Boemi, R Festa, et al.
European Journal of Clinical Nutrition|April 12, 2007
Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations?A A Rivellese, M Boemi, F Cavalot, et al.
Atherosclerosis|December 21, 2007
The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in ItalyO Vaccaro, M Boemi, F Cavalot, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 17, 2007
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 geneR Testa, A R Bonfigli, C Sirolla, et al.
Pageof 4